Pangenomic Health Inc.
Symbol: NARA.CN
CNQ
0.08
CADMarket price today
-0.5178
P/E Ratio
0.0003
PEG Ratio
0.77M
MRK Cap
- 0.00%
DIV Yield
Pangenomic Health Inc. (NARA-CN) Financial Statements
Balance Sheet
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0.1 | 1.3 | 0 | ||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.net-receivables | 0 | 0.2 | 0 | 0.1 | ||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.other-current-assets | 0 | 0.2 | 0.3 | 0 | ||||
balance-sheet.row.total-current-assets | 0 | 0.5 | 1.7 | 0.1 | ||||
balance-sheet.row.property-plant-equipment-net | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.intangible-assets | 0 | 0 | 0.8 | 0 | ||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0.8 | 0 | ||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-non-current-assets | 0 | 0 | 0.9 | 0 | ||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-assets | 0 | 0.5 | 2.6 | 0.1 | ||||
balance-sheet.row.account-payables | 0 | 0.4 | 0.2 | 0 | ||||
balance-sheet.row.short-term-debt | 0 | 0.1 | 0 | 0 | ||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 0 | ||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||
balance-sheet.row.other-current-liab | 0 | 0.2 | 0.2 | 0.1 | ||||
balance-sheet.row.total-non-current-liabilities | 0 | 0.5 | 0 | 0 | ||||
balance-sheet.row.other-liabilities | 0 | -0.5 | 0 | 0 | ||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-liab | 0 | 0.7 | 0.3 | 0.1 | ||||
balance-sheet.row.preferred-stock | 0 | 0 | 0.5 | 0 | ||||
balance-sheet.row.common-stock | 0 | 11.2 | 4.6 | 0.2 | ||||
balance-sheet.row.retained-earnings | 0 | -15 | -3 | -0.3 | ||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 3.5 | 0.1 | 0.1 | ||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-stockholders-equity | 0 | -0.2 | 2.2 | 0 | ||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 0.5 | 2.6 | 0.1 | ||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-equity | 0 | -0.2 | 2.2 | 0 | ||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||
Total Investments | 0 | 0 | 0 | 0 | ||||
balance-sheet.row.total-debt | 0 | 0.1 | 0 | 0 | ||||
balance-sheet.row.net-debt | 0 | 0 | -1.3 | 0 |
Cash Flow Statement
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -12 | -2.6 | -0.1 | ||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 0 | 0 | ||||
cash-flows.row.deferred-income-tax | 0 | 0 | 1.8 | 0 | ||||
cash-flows.row.stock-based-compensation | 0 | 0.6 | 0.1 | 0 | ||||
cash-flows.row.change-in-working-capital | 0 | 0.2 | -0.3 | 0.1 | ||||
cash-flows.row.account-receivables | 0 | -0.1 | 0 | 0 | ||||
cash-flows.row.inventory | 0 | 0.1 | 0 | 0 | ||||
cash-flows.row.account-payables | 0 | 0.2 | 0.1 | 0 | ||||
cash-flows.row.other-working-capital | 0 | 0 | -0.3 | 0.1 | ||||
cash-flows.row.other-non-cash-items | 0 | 8.4 | 0 | 0 | ||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | 0 | 0 | ||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||
cash-flows.row.other-investing-activites | 0 | 0 | -0.6 | -0.1 | ||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -0.1 | -0.6 | -0.1 | ||||
cash-flows.row.debt-repayment | 0 | -0.1 | 0 | 0 | ||||
cash-flows.row.common-stock-issued | 0 | 1.3 | 2.5 | 0.1 | ||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||
cash-flows.row.other-financing-activites | 0 | 0.4 | 0.5 | 0 | ||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 1.6 | 3 | 0.2 | ||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||
cash-flows.row.net-change-in-cash | 0 | -1.3 | 1.3 | 0 | ||||
cash-flows.row.cash-at-end-of-period | 0 | 0.1 | 1.3 | 0 | ||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1.3 | 0 | 0 | ||||
cash-flows.row.operating-cash-flow | 0 | -2.8 | -1.1 | 0 | ||||
cash-flows.row.capital-expenditure | 0 | 0 | 0 | 0 | ||||
cash-flows.row.free-cash-flow | 0 | -2.8 | -1.1 | 0 |
Income Statement Row
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.gross-profit | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.research-development | 0 | - | - | - | ||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.operating-expenses | 0 | 3.6 | 0.9 | 0.1 | ||||
income-statement-row.row.cost-and-expenses | 0 | 3.6 | 0.9 | 0.1 | ||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||
income-statement-row.row.total-other-income-expensenet | 0 | -8.4 | -1.8 | 0 | ||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.total-operating-expenses | 0 | -8.4 | -1.8 | 0 | ||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.depreciation-and-amortization | 0 | 0 | 0 | 0 | ||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||
income-statement-row.row.operating-income | 0 | -3.6 | -0.9 | -0.1 | ||||
income-statement-row.row.income-before-tax | 0 | -12 | -2.6 | -0.1 | ||||
income-statement-row.row.income-tax-expense | 0 | 8.4 | 0 | 0 | ||||
income-statement-row.row.net-income | 0 | -20.3 | -2.7 | -0.1 |
Frequently Asked Question
What is Pangenomic Health Inc. (NARA.CN) total assets?
Pangenomic Health Inc. (NARA.CN) total assets is 504142.000.
What is enterprise annual revenue?
The annual revenue is N/A.
What is firm profit margin?
Firm profit margin is 0.000.
What is company free cash flow?
The free cash flow is -0.016.
What is enterprise net profit margin?
The net profit margin is 0.000.
What is firm total revenue?
The total revenue is 0.000.
What is Pangenomic Health Inc. (NARA.CN) net profit (net income)?
The net profit (net income) is -20347972.000.
What is firm total debt?
The total debt is 101771.000.
What is operating expences number?
The operating expences are 3641827.000.
What is company cash figure?
Enretprise cash is 0.000.